Free Trial

Inspire Medical Systems Q1 2023 Earnings Report

Inspire Medical Systems logo
$176.87 -1.52 (-0.85%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Inspire Medical Systems EPS Results

Actual EPS
-$0.53
Consensus EPS
-$0.70
Beat/Miss
Beat by +$0.17
One Year Ago EPS
-$0.61

Inspire Medical Systems Revenue Results

Actual Revenue
$127.90 million
Expected Revenue
$120.06 million
Beat/Miss
Beat by +$7.84 million
YoY Revenue Growth
+84.30%

Inspire Medical Systems Announcement Details

Quarter
Q1 2023
Time
After Market Closes

Conference Call Resources

Inspire Medical Systems Earnings Headlines

9/9 on TSLA from June to January
Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!
Leerink Partnrs Has Bullish Forecast for INSP Q1 Earnings
FY2028 Earnings Estimate for INSP Issued By Leerink Partnrs
See More Inspire Medical Systems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Inspire Medical Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inspire Medical Systems and other key companies, straight to your email.

About Inspire Medical Systems

Inspire Medical Systems (NYSE:INSP), a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

View Inspire Medical Systems Profile

More Earnings Resources from MarketBeat